Featured
Read our handpicked blogs, curated for you.
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
|
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front…
Recent releases
|
Pilot Paralysis Is Costing Pharma Growth. Time to Scale or Stagnate.
Pharma marketing in India has no shortage of pilots. Every quarter, a new “digital-first” idea is tested. A chatbot here. A WhatsApp drip there. Maybe a webinar series that looked exciting on slides…
|
Your Reps Could Be a Digital Engine. Here’s How to Switch It On.
Why the Field Force Alone Can’t Deliver AnymorePharma has always leaned on reps. They’re the frontline, the face doctors see. But here’s the truth CMOs know: rep-only models don’t work like they used…
|
Adherence = Revenue: The Data Case Pharma CMOs Can’t Afford to Miss
Why Adherence is the Real Growth Lever: Let’s call it straight. For all the money pharma spends on marketing, the biggest gap isn’t awareness. It’s adherence. Doctors prescribe. Patients start. But…
|
Doctors Aren’t Ignoring You. They’re Ignoring Irrelevance
The Myth of Doctor DisengagementPharma marketers often complain that doctors are ignoring them. That reps can’t get meetings. That emails go unopened. That webinars feel like empty rooms. The truth…
